CNMD

CONMED Corporation

Healthcare · $1.4B market cap

Verdict

Share price

$46.32

close of Oct 3, 2026

Fair value

$57.17

Sticker Price

Payback Price

$22.87

buy price

Undervalued

CNMD is Undervalued: at $46.32 it trades 19% below its fair value of $57.17. Its buy price (Payback Price) is $22.87, 51% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth2.5% a year✗
Equity per share growth2.9% a year✗
Sales growth3.2% a year✗
Free cash flow growth7.0% a year✗
Return on invested capital5.8%✗

Follow CNMD

Get notified when it reaches its buy price of $22.87. Free.

Create a free account

Superinvestors

1 of the investors we track holds CNMD. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: Howard Marks

Insider activity

Since Jul 1, 2026: no open-market purchases and 6 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

About CONMED Corporation

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works